Steve Hoffman
Chief Executive Officer bei Tyme, Inc.
Profil
Steve Hoffman was the founder of Tyme Technologies, Inc. (founded in 2011), where he held the title of Chairman & Chief Science Officer from 2020 to 2022.
He was also the founder of Mikronite Technologies Group, Inc. (founded in 1993), where he served as the Chief Technology Officer from 1993 to 2007.
Additionally, he was the founder of Luminant Biosciences LLC (founded in 2011), where he held the title of Chief Executive & Science Officer, Manager from 2015 to 2020.
Currently, Mr. Hoffman is the Chief Executive Officer & Director at Tyme, Inc. since 2013.
Aktive Positionen von Steve Hoffman
| Unternehmen | Position | Beginn |
|---|---|---|
Tyme, Inc.
 Tyme, Inc. BiotechnologyHealth Technology Part of Syros Pharmaceuticals, Inc., Tyme, Inc. is a private company that provides research and development services focused on developing drug candidates for the treatment of cancer. The company is based in Wilmington, DE. Steve Hoffman has been the CEO of the company since 2013. Tyme was acquired by Tyme Technologies, Inc., part of Syros Pharmaceuticals, Inc. from September 19, 2022 on March 05, 2015. | Chief Executive Officer | 01.07.2013 |
Ehemalige bekannte Positionen von Steve Hoffman
| Unternehmen | Position | Ende |
|---|---|---|
| TYME TECHNOLOGIES, INC. | Chief Executive Officer | 24.11.2020 |
| Luminant Biosciences LLC | Chief Executive Officer | 01.10.2020 |
Mikronite Technologies Group, Inc.
 Mikronite Technologies Group, Inc. Auto Parts: OEMProducer Manufacturing Mikronite Technologies Group, Inc. provides material surfacing technologies. The company was founded by Michael Demurjian and Steve Hoffman and is headquartered in Eatontown, NJ. | Founder | 01.01.2007 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Tyme Technologies, Inc.
 Tyme Technologies, Inc. Pharmaceuticals: MajorHealth Technology Tyme Technologies, Inc. operates as a biotechnology company, which engages in the development and commercialization of cancer therapies. It offers a clinical program named SM-88 which is a novel, oral, and monotherapy investigational agent that aims to disrupt the cancer cell's protein synthesis. The company was founded by Steve Hoffman and Michael Demurjian on November 22, 2011 and is headquartered in Bedminster, NJ. | Health Technology |
Mikronite Technologies Group, Inc.
Mikronite Technologies Group, Inc. Auto Parts: OEMProducer Manufacturing Mikronite Technologies Group, Inc. provides material surfacing technologies. The company was founded by Michael Demurjian and Steve Hoffman and is headquartered in Eatontown, NJ. | Producer Manufacturing |
Tyme, Inc.
Tyme, Inc. BiotechnologyHealth Technology Part of Syros Pharmaceuticals, Inc., Tyme, Inc. is a private company that provides research and development services focused on developing drug candidates for the treatment of cancer. The company is based in Wilmington, DE. Steve Hoffman has been the CEO of the company since 2013. Tyme was acquired by Tyme Technologies, Inc., part of Syros Pharmaceuticals, Inc. from September 19, 2022 on March 05, 2015. | Health Technology |
| Luminant Biosciences LLC |
